Some regulators and investors are expressing concerns about
abuse of Rule 10b5-1 plans. Last July, Representative Maxine Waters
introduced the "Promoting Transparency Standards for Corporate
Insiders Act," which would require the SEC to study
whether Rule 10b5-1 should be amended to restricted multiple plans,
require a waiting period before making trades under a plan, and
limit how often plans can be modified or canceled. In December, the
Council of Institutional Investors cited this act in a letter to the SEC arguing for even more
restrictions on Rule 10b5-1 plans.
As supporting evidence, the CII cited a Rule 10b5-1 plan under
which Intel's CEO sold $39 million of stock only weeks before
Intel announced a flaw in its computer chips. The plan had been
amended shortly before the sale and, apparently, after Intel
management was aware of the flaw.